Novel isobavachalcone derivatives induce apoptosis and necroptosis in human non-small cell lung cancer H1975 cells

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol. 2015;10(9):1240–1242.
   PubMed Web of Science ®Google Scholar
• Kocher F, Hilbe W, Seeber A, Pircher A, Schmid T, Greil R, Auberger J, Nevinny-Stickel M, Sterlacci W, Tzankov A, et al. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry. Lung Cancer. 2015;87(2):193–200.
   PubMed Web of Science ®Google Scholar
• Check JH, Poretta T, Check D, Srivastava M. Lung cancer–standard therapy and the use of a novel, highly effective, well tolerated, treatment with progesterone receptor molulators. Anticancer Res. 2023;43(3):951–965.
   PubMed Web of Science ®Google Scholar
• Spiro SG, Rudd RM, Souhami RL, Brown J, Fairlamb DJ, Gower NH, Maslove L, Milroy R, Napp V, Parmar MK, et al. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax. 2004;59(10):828–836.
   PubMed Web of Science ®Google Scholar
• Clegg A, Scott DA, Hewitson P, Sidhu M, Waugh N. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review. Thorax. 2002;57(1):20–28.
   PubMed Web of Science ®Google Scholar
• Lu X, Yu L, Zhang Z, Ren X, Smaill JB, Ding K. Targeting EGFRL858R/T790M and EGFRL858R/T790M/C797S resistance mutations in NSCLC: current developments in medicinal chemistry. Med Res Rev. 2018;38(5):1550–1581.
   PubMed Web of Science ®Google Scholar
• Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, Chen Y, Han B. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7(1):286.
   PubMed Web of Science ®Google Scholar
• Gibellini L, Moro L. Programmed cell death in health and disease. Cells. 2021;10(7):1765.
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–542.
   PubMed Web of Science ®Google Scholar
• Wu Y, Dong G, Sheng C. Targeting necroptosis in anticancer therapy: mechanisms and modulators. Acta Pharm Sin B. 2020;10(9):1601–1618.
   PubMed Web of Science ®Google Scholar
• Yin L, Liu P, Jin Y, Ning Z, Yang Y, Gao H. Ferroptosis-related small-molecule compounds in cancer therapy: strategies and applications. Eur J Med Chem. 2022;244:114861.
   PubMed Web of Science ®Google Scholar
• Morana O, Wood W, Gregory CD. The apoptosis paradox in cancer. Int J Mol Sci. 2022;23(3):1328.
   PubMed Web of Science ®Google Scholar
• Nyiramana MM, Cho SB, Kim EJ, Kim MJ, Ryu JH, Nam HJ, Kim NG, Park SH, Choi YJ, Kang SS, et al. Sea hare hydrolysate-induced reduction of human non-small cell lung cancer cell growth through regulation of macrophage polarization and non-apoptotic regulated cell death pathways. Cancer. 2020;12(3):726.
   Google Scholar
• Wu CZ, Gao MJ, Chen J, Sun XL, Zhang KY, Dai YQ, Ma T, Li HM, Zhang YX. Isobavachalcone induces multiple cell death in human triple-negative breast cancer MDA-MB-231 cells. Molecules. 2022;27(20):6787.
   PubMed Web of Science ®Google Scholar
• Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz M, Yuan J. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1(2):112–119.
   PubMed Web of Science ®Google Scholar
• Lu B, Gong X, Wang ZQ, Ding Y, Wang C, Luo TF, Piao MH, Meng FK, Chi GF, Luo YN, et al. Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 ncrosome formation. Acta Pharmacol Sin. 2017;38(11):1543–1553.
   PubMed Web of Science ®Google Scholar
• Xu B, Xu M, Tian Y, Yu Q, Zhao Y, Chen X, Mi P, Cao H, Zhang B, Song G, et al. Matrine induces RIP3-dependent necroptosis in cholangiocarcinoma cells. Cell Death Discov. 2017;3(1):16096.
   PubMedGoogle Scholar
• Ma YM, Peng YM, Zhu QH, Gao AH, Chao B, He QJ, Li J, Hu YH, Zhou YB. Nover CHOP activator LGH00168 induces necroptosis in A5149 human lung cancer cells via ROS-mediated ER stress and NF-κB inhibition. Acta Pharmacol Sin. 2016;37(10):1381–1390.
   PubMed Web of Science ®Google Scholar
• Sun W, Yu J, Gao H, Wu X, Wang S, Hou Y, Lu JJ, Chen X. Inhibition of lung cancer by 2-methoxy-6-acetyl-7-methyljuglone through induction of necroptosis by targeting receptor-interacting protein 1. Antioxid Redox Signal. 2019;31(2):93–108.
   PubMed Web of Science ®Google Scholar
• Lan W, Santofimia-Castaño P, Xia Y, Zhou Z, Huang C, Fraunhoffer N, Barea D, Cervello M, Giannitrapani L, Montalto G, et al. Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma. Cancer Lett. 2020;486:8–17.
   PubMed Web of Science ®Google Scholar
• Bhalla VX, Nayak UR, Dev S. Some new flavonoids from Psoralea corylifolia. Tetrahedron Lett. 1968;9(20):2401–2406.
   Google Scholar
• Ouyang Y, Li J, Chen X, Fu X, Sun S, Wu Q. Chalcone derivatives: role in anticancer therapy. Biomolecules. 2021;11(6):894.
   PubMed Web of Science ®Google Scholar
• Zhao S, Cui J, Cao L, Han K, Ma X, Chen H, Yin S, Zhao C, Ma C, Hu H. Xanthohumol inhibits non-small cell lung cancer via directly targeting T-lymphokine-activated killer cell-originated protein kinase. Phytother Res. 2023;37(7):3057–3068.
   PubMed Web of Science ®Google Scholar
• Cheah SC, Lai SL, Lee ST, Hadi AH, Mustafa MR. Panduratin A, a possible inhibitor in metastasized A549 cells through inhibition of NG-kappa B translocation and chemoinvasion. Molecules. 2013;18(8):8764–8778.
   PubMed Web of Science ®Google Scholar
• Deng N, Qiao M, Li Y, Liang F, Li J, Liu Y. Anticancer effects of licochalcones: a review of the mechanisms. Front Pharmacol. 2023;14:1074506.
   PubMed Web of Science ®Google Scholar
• Kris MG, Natale RB, Herbst RS, Lynch TJ, Prager D, Belani CP, Schiller JH, Kelly K, Spiridonidis H, Sandler A, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. J Am Med Assoc. 2003;290(16):2149–2158.
   PubMed Web of Science ®Google Scholar
• Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, Campos D, Maoleekoonpiroj S, Smylie M, Martins R, et al. Erlotinib in previously treated non-small cell lung cancer. N Engl J Med. 2005;353(2):123–132.
   PubMed Web of Science ®Google Scholar
• Reck M, Remon J, Hellmann MD. First-line immunotherapy for non-small-cell lung cancer. J Clin Oncol. 2022;40(6):586–597.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang H, Cao J, Zhuo Y, Jin J, Gao Q, Yuan X, Yang L, Li D, Wang Y. Isobavachalcone activates antitumor immunity on orthotopic pancreatic cancer model: a screening and validation. Front Pharmacol. 2022;13:919035.
   PubMed Web of Science ®Google Scholar
• He H, Wang C, Liu G, Ma H, Jiang M, Li P, Lu Q, Li L, Qi H. Isobavachalcone inhibits acute myeloid leukemia: potential role for ROS-dependent mitochondrial apoptosis and differentiation. Phytother Res. 2021;35(6):3337–3350.
   PubMed Web of Science ®Google Scholar
• Shi J, Chen Y, Chen W, Tang C, Zhang H, Chen Y, Yang X, Xu Z, Wei J, Chen J. Isobavachalcone sensitizes cells to E2-induced paclitaxel resistance by down-regulating CD44 expression in ER+ breast cancer cells. J Cell Mol Med. 2018;22(11):5220–5230.
   PubMed Web of Science ®Google Scholar
• Carneiro BA, Ei-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17(7):395–417.
   PubMed Web of Science ®Google Scholar
• Gao W, Xiao F, Wang X, Chen T. Artemisinin induces A549 cell apoptosis dominantly via a reactive oxygen species-mediated amplification activation loop among caspase-9, -8, and -3. Apoptosis. 2013;18(10):1201–1213.
   PubMed Web of Science ®Google Scholar
• Jiao C, Chen W, Tan X, Liang H, Li J, Yun H, He C, Chen J, Ma X, Xie Y, et al. Ganoderma lucidum spore oil induces apoptosis of breast cancer cells in vitro and in vivo by activating caspase-3 and caspase-9. J Ethnopharmacol. 2020;247:112256.
   PubMed Web of Science ®Google Scholar
• Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, Cheng H, Jin K, Ni Q, Yu X, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18(1):100.
   PubMed Web of Science ®Google Scholar
• Silke J, Rickard JA, Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol. 2015;16(7):689–697.
   PubMed Web of Science ®Google Scholar
• Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, Dong MQ, Han J. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science. 2009;325(5938):332–336.
   PubMed Web of Science ®Google Scholar
• Christofferson DE, Li Y, Yuan J. Control of life-or-death decisions by RIP1 kinase. Annu Rev Physiol. 2014;76(1):129–150.
   PubMedGoogle Scholar
• Yao Z, Zhang P, Guo H, Shi J, Liu S, Liu Y, Zheng D. RIP1 modulates death receptor mediated apoptosis and autophagy in macrophages. Mol Oncol. 2015;9(4):806–817.
   PubMed Web of Science ®Google Scholar
• Ofengeim D, Yuan J. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat Rev Mol Cell Biol. 2013;14(11):727–736.
   PubMed Web of Science ®Google Scholar
• Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145–1159.
   PubMed Web of Science ®Google Scholar
• Yang Y, Karakhanova S, Hartwig W, D'Haese JG, Philippov PP, Werner J, Bazhin AV. Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy. J Cell Physiol. 2016;231(12):2570–2581.
   PubMed Web of Science ®Google Scholar
• Moloney JN, Cotter TG. ROS signaling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50–64.
   PubMed Web of Science ®Google Scholar